A citation-based method for searching scientific literature

Annabeth Høgh Petersen, Mads Malik Aagaard, Henriette Roed Nielsen, Karina Dahl Steffensen, Marianne Waldstrøm, Anders Bojesen. Eur J Hum Genet 2016
Times Cited: 9







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
63
44

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
680
44

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
340
33

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836
33

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
35
33

Genetic/familial high-risk assessment: breast and ovarian.
Mary B Daly, Jennifer E Axilbund, Saundra Buys, Beth Crawford, Carolyn D Farrell, Susan Friedman, Judy E Garber, Salil Goorha, Stephen B Gruber, Heather Hampel,[...]. J Natl Compr Canc Netw 2010
161
22

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
37
22

Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
38
22

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
160
22

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
999
22

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
284
22

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
Thomas C Randall, Katrina Armstrong. Curr Treat Options Oncol 2016
18
22

Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations.
Susan M Wolf, Rebecca Branum, Barbara A Koenig, Gloria M Petersen, Susan A Berry, Laura M Beskow, Mary B Daly, Conrad V Fernandez, Robert C Green, Bonnie S LeRoy,[...]. J Law Med Ethics 2015
57
22

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
22

Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.
Carmen Radecki Breitkopf, Gloria M Petersen, Susan M Wolf, Kari G Chaffee, Marguerite E Robinson, Deborah R Gordon, Noralane M Lindor, Barbara A Koenig. J Law Med Ethics 2015
20
22

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Shoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Lidia Schapira, Steven Come, Virginia F Borges, Bryce Larsen, Judy E Garber, Ann H Partridge. JAMA Oncol 2016
72
22

Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.
Laura M Amendola, Martha Horike-Pyne, Susan B Trinidad, Stephanie M Fullerton, Barbara J Evans, Wylie Burke, Gail P Jarvik. J Law Med Ethics 2015
15
22

Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.
M A Adank, E Brogi, F Bogomolniy, E A Wadsworth, K J Lafaro, C J Yee, T Kirchhoff, E J Meijers-Heijboer, N D Kauff, J Boyd,[...]. Fam Cancer 2006
13
22

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
569
22

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
828
22

Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.
Denise Feierabend, Jan Walter, Susanne Grube, Christian Herbold, Christian Beetz, Rolf Kalff, Christian Ewald. J Neurooncol 2014
7
14

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
Jan P Schouten, Cathal J McElgunn, Raymond Waaijer, Danny Zwijnenburg, Filip Diepvens, Gerard Pals. Nucleic Acids Res 2002
11


DNA damage caused by common cytological fixatives.
M P Douglas, S O Rogers. Mutat Res 1998
61
11

DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA.
M Hofreiter, V Jaenicke, D Serre, A von Haeseler, S Pääbo. Nucleic Acids Res 2001
364
11

Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology.
Marlous Hoogstraat, John W J Hinrichs, Nicolle J M Besselink, Joyce H Radersma-van Loon, Carmen M A de Voijs, Ton Peeters, Isaac J Nijman, Roel A de Weger, Emile E Voest, Stefan M Willems,[...]. J Mol Diagn 2015
31
11

Effect of fixatives and tissue processing on the content and integrity of nucleic acids.
Mythily Srinivasan, Daniel Sedmak, Scott Jewell. Am J Pathol 2002
753
11

Systematic biases in DNA copy number originate from isolation procedures.
Sebastiaan van Heesch, Michal Mokry, Veronika Boskova, Wade Junker, Rajdeep Mehon, Pim Toonen, Ewart de Bruijn, James D Shull, Timothy J Aitman, Edwin Cuppen,[...]. Genome Biol 2013
31
11


Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer.
Cathy B Moelans, Roel A de Weger, Marja T M van Blokland, Elsken van der Wall, Paul J van Diest. Mod Pathol 2010
36
11

Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.
Gulisa Turashvili, Winnie Yang, Steven McKinney, Steve Kalloger, Nadia Gale, Ying Ng, Katie Chow, Lynda Bell, Julie Lorette, Melinda Carrier,[...]. Exp Mol Pathol 2012
68
11

Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
Justyna Dopierala, Bertil E Damato, Sarah L Lake, Azzam F G Taktak, Sarah E Coupland. Invest Ophthalmol Vis Sci 2010
71
11

Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
Jason Madore, Fengge Ren, Ali Filali-Mouhim, Lilia Sanchez, Martin Köbel, Patricia N Tonin, David Huntsman, Diane M Provencher, Anne-Marie Mes-Masson. J Pathol 2010
70
11

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.
Andrea Mafficini, Michele Simbolo, Alice Parisi, Borislav Rusev, Claudio Luchini, Ivana Cataldo, Elena Piazzola, Nicola Sperandio, Giona Turri, Massimo Franchi,[...]. Oncotarget 2016
49
11


Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
Katherine Karakasis, Julia V Burnier, Valerie Bowering, Amit M Oza, Stephanie Lheureux. Front Oncol 2016
12
11

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487
11

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
205
11

Attitudes Toward Breast Cancer Genetic Testing in Five Special Population Groups.
Amelie G Ramirez, Patricia Chalela, Kipling J Gallion, Edgar Muñoz, Alan E Holden, Linda Burhansstipanov, Selina A Smith, Evaon Wong-Kim, Stephen W Wyatt, Lucina Suarez. J Health Dispar Res Pract 2015
19
11

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
45
11



Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
57
11

Panel Testing Is Not a Panacea.
Jennifer E Axilbund. J Clin Oncol 2016
13
11

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, Michael F Walsh, Vijai Joseph, Zsofia K Stadler, Katherine L Nathanson, Judy E Garber, Fergus J Couch, Kenneth Offit,[...]. J Clin Oncol 2016
100
11

Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer.
Veronica I Lagos, Martin A Perez, Charité N Ricker, Kathleen R Blazer, Nydia M Santiago, Nancy Feldman, Lori Viveros, Jeffrey N Weitzel. Psychooncology 2008
40
11

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
224
11

GINA, genetic discrimination, and genomic medicine.
Robert C Green, Denise Lautenbach, Amy L McGuire. N Engl J Med 2015
98
11

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
707
11

Impact of subsidies on cancer genetic testing uptake in Singapore.
Shao-Tzu Li, Jeanette Yuen, Ke Zhou, Nur Diana Binte Ishak, Yanni Chen, Marie Met-Domestici, Sock Hoai Chan, Yee Pin Tan, John Carson Allen, Soon Thye Lim,[...]. J Med Genet 2017
16
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.